Cathay Biotech Inc.’s Net Profit Rose 13.3% in First Half of 2022

Cathay Biotech Inc. (上海凯赛生物技术股份有限公司) (688065.SH) reported a net profit of 368.3 million yuan in the first half of 2022, up 13.3% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 13.5% year-on-year.

At the end of the reporting period, it had 16.7 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 11.1%.